THE Society of Hospital Pharmacists of Australia (SHPA) has acknowledged Adjunct Associate Professor Steve Morris (pictured) as incoming Chief Executive Officer (CEO) of the Pharmaceutical Society of Australia (PSA) at a time of "great opportunity to improve medication safety through advancing the specialised skills of Australia's pharmacists and technicians".
On behalf of the Board of Directors, branches and members across the country, SHPA Acting Chief Executive Nick Sharp-Paul welcomed Morris, who is a former SHPA Board Director and award winner.
"Steve has deep connections to SHPA as a former Director, recipient of our prestigious 2019 Fred J Boyd Award and the time in his career working in the hospital setting, during which he was integral in establishing SA Pharmacy.
"Since stepping down from the SHPA Board, Steve was a visionary leader of NPS MedicineWise, dedicated to better clinician and consumer decision-making in health to improve both health and economic outcomes in Australia.
"This year we will welcome the pharmacy world to Brisbane for the 81st FIP World Congress of Pharmacy and Pharmaceutical Sciences, a fantastic chance to showcase the inter-professional alignment between two of Australia's venerable pharmacy organisations.
Sharp-Paul thanked the outgoing PSA CEO Mark Kinsela on his tenure "whose leadership over the past few years has spanned several important collaborations".
The above article was sent to subscribers in Pharmacy Daily's issue from 20 Jun 23
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 20 Jun 23
